Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Treasury Shares (2021 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Treasury Shares for 4 consecutive years, with $249500.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed N/A to $249500.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $249500.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $249500.0 for FY2025, N/A changed from the prior year.
  • Treasury Shares hit $249500.0 in Q4 2025 for Bolt Biotherapeutics, up from $52533.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $336000.0 in Q4 2021 to a low of $52533.0 in Q4 2023.
  • Historically, Treasury Shares has averaged $189975.0 across 4 years, with a median of $185683.5 in 2022.
  • Biggest five-year swings in Treasury Shares: tumbled 63.73% in 2022 and later tumbled 56.89% in 2023.
  • Year by year, Treasury Shares stood at $336000.0 in 2021, then crashed by 63.73% to $121867.0 in 2022, then crashed by 56.89% to $52533.0 in 2023, then soared by 374.94% to $249500.0 in 2025.
  • Business Quant data shows Treasury Shares for BOLT at $249500.0 in Q4 2025, $52533.0 in Q4 2023, and $121867.0 in Q4 2022.